Hemodialysis and Peritoneal Dialysis Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Hemodialysis and Peritoneal Dialysis Market size was valued at USD 118.29 Billion in 2025 and is anticipated to grow at a 9.2% CAGR from 2026 to 2035, exceeding USD 285.22 Billion by 2035. The industry revenue for 2026 is assessed at USD 127.77 billion.

• Base Year Value (2025): USD 118.29 Billion
• CAGR (2026-2035): 9.2%
• Forecast Year Value (2035): USD 285.22 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Hemodialysis and Peritoneal Dialysis Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America accounted for 40.55% of the market in 2025, supported by established dialysis infrastructure, broad treatment access, mature reimbursement systems, and organized renal care networks.
  • Asia Pacific is expected to grow at a 10.4% CAGR, driven by expanding dialysis capacity, improving access to renal care, earlier diagnosis, and wider adoption of both in-center and home-based treatments.

• Segment Momentum:

  • Hemodialysis held a 78.57% share in 2025 due to its established clinical infrastructure, scalable in-center treatment capacity, and widespread reliance on supervised therapy delivery for long-term renal replacement care.
  • Home-based care is the fastest-growing segment as patients and providers increasingly prefer flexible dialysis solutions that reduce dependence on facility-based scheduling and better support everyday lifestyle needs.

• Market Expansion Drivers:

  • Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand.
  • Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility.
  • Growing investments in renal care infrastructure across emerging economies expanding treatment access.

• Leading Market Participants:

  Leading players in the hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG (Germany), Baxter International Inc. (United States), B. Braun SE (Germany), Nipro Corporation (Japan), Asahi Kasei Medical Co., Ltd. (Japan), Medtronic plc (Ireland), Becton, Dickinson and Company (United States), Nikkiso Co., Ltd. (Japan), DaVita Inc. (United States), Diaverum AB (Sweden).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 118.29 Billion
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 285.22 Billion by 2035
  • Growth Forecasts: 9.2% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hemodialysis (Type) | Hospital-based (End-use) | Services (Product)
  • Emerging Opportunity Segment: Hemodialysis (Type) | Home-based (End-use) | Consumables (Product)

Market Growth Drivers and Industry Trends

Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand

The rising burden of chronic kidney disease linked to diabetes and hypertension is steadily enlarging the treated patient pool for the hemodialysis and peritoneal dialysis market, as these two conditions are among the most common pathways to progressive renal decline and eventual kidney failure. In practice, This trends dialysis from a niche intervention to a recurring long-term therapy requirement, increasing procedure volumes, consumables use, and demand for installed equipment in hospitals, clinics, and outpatient renal centers. The effect is especially pronounced because patients often enter dialysis after extended disease management, creating a sustained flow of new cases that supports market expansion rather than a short-cycle spike in demand.

Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility

Expansion of home-based dialysis and portable systems is influencing adoption patterns in the hemodialysis and peritoneal dialysis market by reducing dependence on fixed-center treatment schedules and lowering access barriers for patients who face travel, time, or mobility constraints. This changes purchasing and care-delivery decisions: providers and payers increasingly evaluate therapies based not only on clinical suitability but also on whether they can support remote use, patient training, and continuity outside traditional dialysis facilities. As a result, product development is moving toward user-friendly machines, compact formats, and monitoring capabilities that strengthen market development by making dialysis more compatible with everyday living and broader patient eligibility.

Growing investments in renal care infrastructure across emerging economies expanding treatment access

Growing investments in renal care infrastructure across emerging economies are contributing to market size growth in the hemodialysis and peritoneal dialysis market by expanding the physical and clinical capacity needed to diagnose renal failure earlier and initiate therapy in places where treatment availability has historically been limited. New dialysis centers, upgraded hospital capabilities, procurement of machines, and improved supply chains for dialyzers and fluids directly increase the number of patients who can be treated on a consistent basis. This infrastructure buildout also supports market penetration by bringing trained personnel and more reliable service networks into underserved regions, allowing dialysis providers and manufacturers to operate with greater continuity and reach.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand	2.00%	High	North America, Asia Pacific, Europe	High	Near Term
Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility	1.60%	High	North America, Europe	High	Mid Term
Growing investments in renal care infrastructure across emerging economies expanding treatment access	1.40%	High	Asia Pacific, Latin America, Middle East & Africa	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 40.55% share of the hemodialysis and peritoneal dialysis market. Its leadership is supported by a well-established dialysis care infrastructure, broad availability of treatment centers, and consistent patient access to maintenance therapy for chronic kidney disease and end-stage renal disease. The region’s mature reimbursement environment and strong clinical management pathways also sustain procedure volumes in practice, as patients typically require recurring dialysis sessions delivered through organized provider networks and specialized renal care facilities.

Asia Pacific is projected to expand at a 10.4% CAGR over the forecast period in the hemodialysis and peritoneal dialysis market. Growth is being propelled by rising treatment demand across densely populated countries, alongside improving access to renal care services and expanding dialysis capacity. As healthcare systems add more treatment centers and widen availability of kidney care, adoption is accelerating in practical terms through greater patient inclusion, earlier diagnosis, and increased use of both in-center and home-based dialysis modalities.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Developing
Cost-Sensitive Region	Low	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Supportive	Restrictive	Restrictive
Demand Drivers	Strong	Strong	Moderate	Moderate	Moderate
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	Medium	Low	Low
New Entrants / Startups	Dense	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Strong	Stable	Stable	Weak

Key Country Insights

United States

Home Dialysis Expansion

The U.S. continues expanding home-based dialysis options alongside established center-based treatment services. Healthcare providers increasingly promote technologies that improve patient convenience, treatment flexibility, and long-term disease management.

Japan

Aging Patient Support

Japan prioritizes dialysis solutions designed for an aging population requiring consistent long-term renal care. Medical institutions in Japan increasingly adopt compact equipment and patient-focused technologies that improve treatment efficiency and comfort.

South Korea

Digital Dialysis Integration

South Korea incorporates digital monitoring and connected healthcare technologies into dialysis services for improved clinical oversight. Providers in South Korea are expanding patient-centered treatment models that support both hospital and home dialysis settings.

Germany

Quality Renal Care

Germany emphasizes clinically reliable dialysis systems supported by standardized treatment protocols and advanced medical infrastructure. Healthcare providers in Germany continue investing in efficient dialysis technologies that enhance patient care and operational performance.

France

Coordinated Renal Services

France focuses on integrated dialysis care delivered through hospitals, specialized clinics, and community healthcare networks. Healthcare organizations in France continue adopting advanced equipment that supports consistent treatment quality and patient outcomes.

Italy

Accessible Dialysis Networks

Italy strengthens dialysis care through broad treatment availability and modernization of renal care facilities. Healthcare providers in Italy increasingly evaluate technologies that simplify treatment delivery while supporting long-term patient management.

Segment Leadership and Growth Trends

  Type Segment Analysis: Hemodialysis (Largest & Fastest-Growing Segment)

Hemodialysis held a 78.57% share of the hemodialysis and peritoneal dialysis market in 2025, reflecting its entrenched role as the primary dialysis modality across routine renal replacement care. its position is maintained through the broad availability of hemodialysis infrastructure, established clinical workflows, and the high dependence on supervised treatment settings for patients requiring regular and closely managed therapy. The same structural advantages are also supporting continued growth in the hemodialysis and peritoneal dialysis market, as providers continue to rely on scalable in-center treatment capacity and standardized care delivery for a large patient base, allowing Hemodialysis to expand faster than alternative modalities within existing care networks.

End-use Segment Analysis: Hospital-based (Largest Segment) vs Home-based (Fastest-Growing Segment)

Hospital-based settings accounted for a 73.68% share of the hemodialysis and peritoneal dialysis market in 2025, maintaining their lead because dialysis treatment often requires direct clinical oversight, access to specialized equipment, and the ability to manage patients with complex comorbidities. This concentration of skilled personnel and treatment infrastructure keeps Hospital-based care at the center of service delivery in the hemodialysis and peritoneal dialysis market, particularly where regular monitoring and immediate medical support remain essential to patient management.

Home-based care is emerging as the fastest-growing end-use segment in the hemodialysis and peritoneal dialysis market as treatment models increasingly shift toward convenience, flexibility, and reduced dependence on facility-based scheduling. Its momentum is tied primarily to the practical appeal of receiving long-term dialysis in a familiar setting, which can better align with patient lifestyle needs and relieve pressure on hospital resources, giving Home-based treatment a stronger growth path than conventional facility-centered alternatives.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Hemodialysis, Peritoneal Dialysis	Hemodialysis	Hemodialysis
End-use	Home-based, Hospital-based	Hospital-based	Home-based
Product	Device, Consumables, Services	Services	Consumables

Competitive Landscape and Market Positioning

Key companies in the hemodialysis and peritoneal dialysis market:

1. Fresenius Medical Care AG (Germany)

2. Baxter International Inc. (United States)

3. B. Braun SE (Germany)

4. Nipro Corporation (Japan)

5. Asahi Kasei Medical Co. Ltd. (Japan)

6. Medtronic plc (Ireland)

7. Becton Dickinson and Company (United States)

8. Nikkiso Co. Ltd. (Japan)

9. DaVita Inc. (United States)

10. Diaverum AB (Sweden)

Growing prevalence of chronic kidney conditions is increasing demand for advanced renal replacement therapies. The hemodialysis and peritoneal dialysis market is witnessing improvements in treatment efficiency and patient monitoring systems. Enhanced device portability and automation are improving treatment accessibility. Continuous innovation in dialysis membranes is also supporting better clinical outcomes.

Industry Development/News

Company Name	Date	Key Development
Nephrodite	Aug-24	Nephrodite received FDA Breakthrough Device Designation for its implantable continuous dialysis platform, designed to operate externally to the body for continuous kidney function replacement. The designation accelerates regulatory engagement and development pathways for a novel dialysis modality aimed at transforming kidney replacement therapy beyond conventional hemodialysis and peritoneal dialysis approaches.
Outset Medical	Jan-26	Outset Medical secured FDA 510(k) clearance for its next-generation Tablo Hemodialysis System, marking a key regulatory milestone. The upgraded platform incorporates enhanced hardware, operating system improvements, and strengthened software aligned with updated cybersecurity standards introduced in 2025, supporting improved system performance, reliability, and clinical usability in dialysis delivery.
Fresenius Medical Care AG & Co. KGaA	Jun-25	Fresenius Medical Care expanded U.S. commercialization of its 5008X CARE system following FDA 510(k) clearance, enabling broader deployment of high-volume hemodiafiltration therapy. The initiative advances adoption of next-generation dialysis modalities across U.S. clinical networks and strengthens positioning of hemodiafiltration as a potential emerging standard of care for chronic kidney disease management.
Rockwell Medical	Jul-23	Rockwell Medical completed the acquisition of Evoqua Water Technologies’ hemodialysis concentrates business, strengthening its position in dialysis consumables. The transaction enhances Rockwell’s supply chain integration and expands its presence in critical dialysis treatment inputs, supporting greater control over manufacturing and distribution of concentrates used in hemodialysis treatment.
Nextkidney BV	Jan-22	Nextkidney BV acquired Dialyss Pte Ltd, expanding its technological capabilities in home hemodialysis systems. The acquisition strengthens Nextkidney’s development pipeline and supports advancement of home-based renal care solutions, enhancing its positioning in the growing decentralized dialysis segment focused on patient-managed treatment environments.
DaVita	Mar-21	DaVita entered an agreement with Fresenius Medical Care to expand utilization of NxStage home hemodialysis machines. The collaboration supports broader adoption of home-based dialysis therapies, reinforcing strategic efforts to shift treatment delivery away from in-center care toward more flexible, patient-centric home hemodialysis models across the dialysis ecosystem.
Mozarc Medical	Sep-25	Mozarc Medical partnered with DK Medical Technology to strengthen PTA balloon technology capabilities for the U.S. arteriovenous access market. The collaboration focuses on improving vascular access solutions, a critical component of hemodialysis treatment infrastructure, supporting enhanced procedure reliability and access management in dialysis patient care pathways.
Dialyze Direct	Aug-23	Dialyze Direct and Northeast Georgia Health Ventures established a strategic collaboration to deliver home dialysis services within skilled nursing facilities in Georgia. The initiative expands access to decentralized dialysis care in long-term care settings, supporting integration of chronic kidney treatment services into institutional care environments.
Fresenius Medical Care	Aug-23	Fresenius Medical Care partnered with Sarah Bush Lincoln to launch a rural dialysis program in Illinois, enabling on-site dialysis services for underserved populations. The collaboration expands geographic access to kidney care services and strengthens Fresenius’ presence in rural healthcare delivery networks through localized treatment infrastructure deployment.